News | June 07, 2022
PM-JAY public dashboard gets revamped with new features
The dashboard will serve as a single source of truth for public and PM-JAY stakeholders providing comprehensive view of scheme’s progress
The dashboard will serve as a single source of truth for public and PM-JAY stakeholders providing comprehensive view of scheme’s progress
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of ALK-mutant NSCLC in China is estimated to grow at a CAGR of 5.3% from 22,725 in 2021 to 31,902 in 2029
Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine
Subscribe To Our Newsletter & Stay Updated
